Intralipid: Difference between revisions

(Text replacement - "*Pancreatitis" to "*Pancreatitis")
Line 39: Line 39:
*Excretion:  
*Excretion:  
*Mechanism of Action:
*Mechanism of Action:
 
** Emulsion acts as a “lipid sink,” surrounding a lipophilic drug molecule and rendering it ineffective
**Fatty acids from the ILE provide the myocardium with a ready energy source, improving cardiac function


==Comments==
==Comments==

Revision as of 19:00, 6 May 2017

General

Adult Dosing

  • 1.5 ml/kg bolus[1]
    • Followed by 0.25 ml/kg/min for 20 min or until hemodynamic stability is achieved.[2]

Pediatric Dosing

Special Populations

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

  • Asystole (case reported) [3]

Common

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:
  • Mechanism of Action:
    • Emulsion acts as a “lipid sink,” surrounding a lipophilic drug molecule and rendering it ineffective
    • Fatty acids from the ILE provide the myocardium with a ready energy source, improving cardiac function

Comments

See Also

External Links

References

  1. Cave, G. Intravenous Lipid Emulsion as Antidote Beyond Local Anesthetic Toxicity: A Systematic Review. 2009. 16(9)815–824
  2. Dillane D, Finucane BT. Local anesthetic systemic toxicity. Can J Anaesth. 2010 Apr;57(4):368-80.
  3. Cole JB et al. Asystole immediately following intravenous fat emulsion for overdose. J Med Toxicol. 2014;10(3)307-310
  4. 4.0 4.1 Kostic MA and Gorelick M. Review of the use of lipid emulsion in nonlocal anesthetic poisoning. Pediatric Emergency Care 2014;30:427-436